Minocycline HCl IR Pellets are pharmaceutical-grade multiparticulate pellets containing Minocycline Hydrochloride and designed for immediate-release oral dosage-form development. The pellet format provides a flexible intermediate for capsule filling and other multiparticulate pharmaceutical formulations.
Minocycline Hydrochloride is identified by CAS Number 13614-98-7, with molecular formula C₂₃H₂₇N₃O₇·HCl and molecular weight 493.94 g/mol. A separate material, Minocycline Hydrochloride Dihydrate, is identified by CAS 128420-71-3 and has a molecular weight of 529.97 g/mol. These materials should not be treated as interchangeable in product specifications.
Commercial pharmaceutical-pellet information confirms that Minocycline HCl Pellets are part of the Indian pellet-development landscape, although one current listing identifies the product as under development and does not establish a universal finished-pellet loading.
Minocycline Hydrochloride IR Pellets provide a pellet-based formulation platform for manufacturers developing immediate-release multiparticulate oral dosage forms.
The final characteristics of the pellets depend on formulation composition, active loading, pelletization process, particle-size distribution, excipient system and manufacturing conditions. Therefore, finished-pellet parameters should be established according to the applicable product specification rather than copied from the Minocycline HCl raw-material specification.
For Minocycline HCl IR Pellets Manufacturer in India searches, the strongest relevance comes from combining the exact product name with Immediate Release Pellets, Pharmaceutical Pellets, Pharmaceutical Grade, Manufacturer India, Supplier India, Multiparticulate Pellets and Capsule Filling terms naturally throughout the page.
Minocycline HCl IR Pellets can be considered for:
Minocycline HCl IR Pellets may be manufactured using suitable pelletization, layering or other multiparticulate processing technologies.
Important product parameters can include:
The final acceptance limits should be established through the validated Minocycline HCl IR Pellets product specification.
Minocycline HCl IR Pellets may be evaluated for:
Minocycline-related impurities can require particular analytical attention because degradation can produce related compounds such as 4-epiminocycline and other degradation products.
Minocycline HCl IR Pellets from Swapnroop are positioned as pharmaceutical-grade multiparticulate pellets for immediate-release formulation development and capsule-filling applications.
Minocycline HCl IR Pellets can be supplied in suitable pharmaceutical bulk packaging according to the applicable product specification. Active loading, pellet size, packaging configuration and analytical requirements should be confirmed before commercial supply.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Heavy Metals | NMT 50 ppm |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 2.0% |